Skip to main content
. 2022 Jul 14;62(4):527–531. doi: 10.2169/internalmedicine.0037-22

Table 1.

Clinical Profiles of the Patients.

PD (n=6)
M/F 3/3
Age, years; range 76.8±6.5; 69-87
Disease duration, years 5.3±3.6
Hoehn and Yahr stage 3.3±0.8
Anti-parkinsonian medication, n (%)
Levodopa 6 (100.0)
Pramipexole 1 (16.7)
Rotigotine 2 (66.7)
Selegiline 2 (66.7)
Amantadine 2 (66.7)
Istradefylline 2 (66.7)
Levodopa equivalent daily dose, mg/day 415.7±173.6

Data are shown as mean±standard deviation or n (%).

PD: Parkinson’s disease, M: male, F: female